Early Termination of License. The License allows for early termination by Dallas Main in the following circumstances: (a) uncured interference if the cause cannot be determined by Dallas Main, or (b) default of the License by licensee. In the event the License is terminated prior to expiration of the License by Dallas Main or its successor, the Equipment Manager shall remove all of Bus Radio Equipment installed in the Building and leave thespace and equipment room in the same condition existing prior to occupying the space, ordinary wear and tear excepted, within ten (10) days following the termination. The Parties will reimburse the Equipment Manager of their proportionate share of such costs. Upon request of a Party within thirty (30) days following termination, that Party's repeater and associated radio equipment will be made available by the Equipment Manager for retrieval by the requesting Party. Any property remaining will be deemed abandoned and may be sold or disposed of by the Equipment Manager.
Early Termination of License. Pursuant to the Governance Agreement, RPR ----------------------------- has certain options to continue the rights specified in the Governance Agreement, including rights specified in this Agreement. Notwithstanding anything else to the contrary contained in this Agreement, the License and this Agreement shall terminate automatically and be of no further force or effect in the event that RPR does not (a) pay the Second Option Payment to ABI before the expiration of the First Option Period, or (b) deliver the Third Option Event Notice before the expiration of the Second Option Period, all in accordance with the terms of the Governance Agreement.
Early Termination of License. Subject to the terms of this Agreement, the License granted to Licensee in the Territory shall terminate if Licensee does not initiate and begin enrollment of patients in at least one Phase 2 dermal clinical trial within the Territory within three (3) years from the execution date of this Agreement. In such a case, this Agreement shall be automatically terminated.
Early Termination of License. Subject to the terms of this Agreement, the License granted to Licensee regarding the countries of Australia, New Zealand, and Kazakhstan, shall terminate if Licensee does not initiate and begin enrollment of patients in at least one Phase 2 ophthalmic clinical trial in Australia within three (3) years from the execution date of this Agreement. In such a case, such rights regarding Australia, New Zealand, and Kazakhstan shall be automatically terminated.
Early Termination of License. Subject to the terms of this Agreement, the License granted to Licensee with respect to the countries of Australia, New Zealand, and Kazakhstan, shall terminate if Licensee does not receive regulatory approval of Licensed Product for marketing and sale from the Therapeutic Goods Administration (TGA) in Australia on or before March 31, 2021.
Early Termination of License. Subject to the terms of this Agreement, the licenses granted to Licensee under this Section 2.1 shall terminate if Licensee does not begin either randomization or dosing of patients in a Licensee-sponsored clinical trial of the Product in (i) Neurotrophic Keratopathy on or before the first anniversary of the Effective Date and (ii) Dry Eye Syndrome on or before the second anniversary of the Effective Date, unless such delay in commencement with regards to Neurotrophic Keratopathy and/or Dry Eye Syndrome arose or resulted from or was caused by a directive of the FDA with regard to requirements for regulatory or CMC matters for the Product or such clinical trial.
